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Inhibition of Vaccinia Virus Growth by the
Virazole or Ribavirin (I-fl-D-ribofuranosyl-I ,z,4-triazole-3-carboxamide) inhibits the growth of vaccinia virus at a concentration of 50 #g/ml. Although vaccinia virus DNA and polypeptides are made to a certain extent in the presence of Virazole, the DNA fails to acquire resistance to deoxyribonuclease and virus particles are not formed. Reversibility of the antiviral effect occurs when the drug is washed out from the infected cultures or when guanosine at an equimolar concentration is added.
Virazole or Ribavirin 0-fl-ribofuranosyl-I,2,4-triazole-3-carboxamide) is a synthetic nucleoside which inhibits the growth of several viruses containing RNA or DNA, including vaccinia virus, in tissue culture and in animals (see review by Sidwell et aI. I974). The mechanism by which it exerts the antiviral activity is not clear yet; however, enzymic studies suggested that Virazole might inhibit GMP synthesis in the infected cells, at a step involving conversion of IMP to xanthosine 5'-phosphate (Streeter et aI. I973) .
In the present study we examined the effect of the drug on the synthesis of vaccinia virus DNA and followed the fate of the newly synthesized DNA in the infected cells.
First, the toxicity of Virazole to BSC I cells was followed. Microscopic observations did not reveal cell death at Virazole concentrations up to 5o #g/ml, even a week following addition of the drug. This concentration of Virazole did not affect incorporation of radioactive thymidine, urine and leucine in infected and uninfected cells into trichloroacetic acid (TCA)-precipitable material for 5 h.
The effect of Virazole on the growth of vaccinia virus (WR strain) in BSC t cells was studied. Cells were infected at an input multiplicity of IO p.f.u.lcell and virus yield 22 h post infection (p.i.) was determined by plaque assay on BSC r cell monolayers (Katz, Margalith & Winer, t974) . Fifty #g/ml of Virazole inhibited virus growth more than tenfold while 25 #g per ml caused only a twofold decrease. Virazole concentrations of I2"5 #g/ml and lower were not effective. Hence the range of drug concentrations which inhibit virus growth, without affecting cell growth, is quite narrow. The antiviral activity of Virazole, against measles, herpes and influenza viruses can be reversed upon its removal or following addition ofguanosine or xanthosine (Sidwell et al. t974; Oxford, I975) . When the growth of vaccinia virus in the presence of both Virazole (5o #g/ml) and an equimolar concentration of guanosine (6o/~g/ml) was studied, no inhibition occurred. Washing of Virazole from infected cells, even at 7 h p.i. resulted in a normal yield of infectious virus in the culture I5 h later.
The time when Virazole is added to infected cultures is critical for the inhibition of virus growth. The drug was more efficient when added at I or 2 h p.i. but lost most of its antiviral capability when given at 6 or 8 h p.i. This finding suggests that Virazole affects an early event in the course of vaccinia virus growth cycle. One of the early events during vaccinia virus infection is the synthesis of its DNA (Salzman, 196o; Joklik & Becker, 1964) . Since vaccinia virus replicates within the cytoplasm of the cells, it is possible to follow DNA synthesis of the virus by addition of radioactive thymidine to infected cultures and measurement of radioactivity incorporated into the TCA-precipitable fraction of the cell cytoplasm (Joklik & Becket, I964) . This method, with a few modifications, was used to follow the effect of Virazole on DNA synthesis of vaccinia virus. BSC I cells in 6o mm plastic Petri dishes were infected with vaccinia virus at an m.o.i, of IO p.f.u./ceU. Following adsorption for 3o rain, Eagle's medium supplemented with 2 ~ calf serum, without or with Virazole (50 #g/ml), was added. At intervals 4 #Ci/ml of 3H-thymidine (11"5 Ci/mmol, Nuclear Research Centre, Negev, Israel) was added for IO rain. The cells were washed and resuspended in I ml of IO m~-tris (hydroxymethyl) aminomethane, Io mM-NaC1 and I"5 mM-MgCI~, pH 7"4 (RSB), containing 0"5 ~o NP 4o. Nuclei were removed by sedimentation at Iooog for 2 min. Radioactivity of TCA-precipitable material from the cytoplasm of the cells was measured byliquid scintillation counting. Fig. I demonstrates a significant decrease in virus DNA synthesis caused by Virazole later than 3 h after infection, while the level of synthesis during the first 3 h is not affected by the drug.
The fate of the newly synthesized DNA of vaccinia virus and its ability to be incorporated into mature virus particles in the presence of Virazole was then studied. BSC I cells were infected with vaccinia virus at an m.o.i, of IO p.f.u./cell. Following 3o min at 37 °C the cultures were washed and Eagle's medium containing 2 ~o calf serum without or with Virazole (5o #g]ml) was supplied. Two hours p.i. 3H-thymidine (Io #Ci/ml) was added and the cultures were harvested 2o h later. Virus particles were isolated by sedimentation in sucrose gradient, as previously described (Katz & Moss, 197o) . The results shown in Fig. 2(a) indicate that virus particles were not formed in the presence of Virazole. Since no virus particles were observed in the infected cells in the presence of Virazole we investigated whether any other deoxyribonuclease-resistant virus structures were formed under these conditions.
Joklik & Becket 0964) observed that vaccinia virus DNA started to become resistant to deoxyribonuclease approx. 5 h p. The sensitivity to deoxyribonuclease of vaccinia virus DNA in the cytoplasm of the infected cells was followed between 4 and 28 h p.i. in the absence and presence of Virazole. Infected BSC I cells were labelled with ZH-thymidine (IO #Ci]ml) between 1.5 and 3 h p.i. The cells were then washed and medium containing unlabelled thymidine (o.oo I mM) was added.
Cultures were removed at intervals, the cells were washed, resuspended in I mM-sodium phosphate (pH 7"o), disrupted with a Dounce homogenizer and the cytoplasmic fraction was isolated. One portion of the cytoplasm was directly precipitated with TCA and another was first digested with deoxyribonuclease (5o #g/ml; Worthington) in IO mM-MgC12 for 30 rain at 37 °C. The percentage of deoxyribonuclease-resistant DNA was calculated. The results presented in Fig. 2 (b) show that approx. 8o ~ of the virus DNA remained sensitive to deoxyribonuclease for 28 h in the presence of Virazole, while less than 4o ~ of the DNA was sensitive to the enzyme in the control cultures. The labelled DNA made in the presence of Virazole was converted to a deoxyribonuclease-resistant form when the drug was removed at 8 h p.i. (Fig. 2 b) . Since the failure of vaccinia DNA to form virus particles in the presence of Virazole might result from absence of structural polypeptides, we followed the synthesis of vaccinia virus polypeptides in the presence of the drug. Host protein synthesis is progressively inhibited after vaccinia virus infection, thus enabling specific labelling of virus polypeptides (Shatkin, i963; Holowczak & Joklik, i967; Salzman & Sebring, 1967; Moss, I968; Moss & Salzman, 1968) . BSC I cells were infected with vaccinia virus at an m.o.i, of IO p.f.u./cell. Thirty rain p.i. Eagle's medium containing 5 ~ of the regular concentration of methionine and 2 ~oo calf serum was added. Two hours p.i. 3 #Ci/ml of aSS-methionine (290 Ci/mmol, Amersham, England) were added. At 7 h p.i. the cells were washed with buffered saline, suspended in RSB, Dounce homogenized and the polypeptides in the cytoplasmic extract 33o
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were examined by SDS-polyacrylamide gel electrophoresis (Summers, Maizel & Darnell, I965) . No qualitative differences were observed between the polypeptides synthesized in the absence and presence of Virazole (5o#glml), although the level of synthesis was decreased in the presence of the drug. Thus, although vaccinia virus polypeptides are apparently synthesized in the presence of Virazole, they fail to coat the virus DNA, converting it into deoxyribonuclease-resistant structures. The cause for this failure, whether it is a nonfunctional DNA or a defective protein which is synthesized in the presence of Virazole, needs further elucidation.
